Duali-Q

IMedis

IMedis Duali-Q aims to optimize the QA process by performing automatic QA on every CT scan and accompanying report to uncover actionable failure points, helping to enhance radiology performance, reducing the risk to providers and improving outcomes for patients.

Information source: Public
Last updated: October 25, 2022

General Information

General
Product name	Duali-Q
Company	IMedis
Subspeciality	Chest, Abdomen
Modality	CT
Disease targeted	Liver cancer, lung cancer, pancreatic cancer, aorta dilation
Key-features	Radiology report assessment of liver lesions, pulmonary nodules, pancreatic lesions, thoracic and abdominal aorta dilation.
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE	Certified, Class I , MDD
FDA	No or not yet
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers